BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9884804)

  • 1. Matrix metalloproteinase-1 in cholesteatoma, middle ear granulations and deep meatal skin: a comparative analysis.
    Banerjee AR; James R; Narula AA; Lee RJ
    Clin Otolaryngol Allied Sci; 1998 Dec; 23(6):515-9. PubMed ID: 9884804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase-2 and matrix metalloproteinase-9 in cholesteatoma and deep meatal skin.
    Banerjee AR; James R; Narula AA
    Clin Otolaryngol Allied Sci; 1998 Aug; 23(4):345-7. PubMed ID: 9762497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The localization of matrix metalloproteinases-8 and -13 in cholesteatoma, deep-meatal and post-auricular skin: a comparative analysis.
    Mehta D; Daudia A; Birchall JP; Banerjee AR
    Acta Otolaryngol; 2007 Feb; 127(2):138-42. PubMed ID: 17364344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of matrix metalloproteinase 1 in cholesteatoma and deep meatal skin.
    Banerjee AR; Jones JL; Birchall JP; Powe DG
    Otol Neurotol; 2001 Sep; 22(5):579-81. PubMed ID: 11568661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gelatinolytic activity of matrix metalloproteinases 2 and 9 in middle ear cholesteatoma.
    Suchozebrska-Jesionek D; Szymański M; Kurzepa J; Gołabek W; Stryjecka-Zimmer M
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):628-32. PubMed ID: 19128667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of matrix metalloproteinases in keratinocytes by cholesteatoma debris and granulation tissue extracts.
    Schmidt M; Grünsfelder P; Hoppe F
    Eur Arch Otorhinolaryngol; 2000; 257(8):425-9. PubMed ID: 11073191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal expression of matrix metalloprotease-9 in middle ear cholesteatomas.
    Shibosawa E; Tsutsumi K; Takakuwa T; Takahashi S
    Am J Otol; 2000 Sep; 21(5):621-4. PubMed ID: 10993447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of matrix metalloproteinasa-2,9 in cholesteatoma and middle ear cancer].
    Zhu W; Xie Y; Wang P
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Apr; 36(2):119-22. PubMed ID: 12761978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of phospholipase C-gamma1 in experimental cholesteatoma using Mongolian gerbils.
    Park K; Chun YM; Lee DH
    Acta Otolaryngol; 2001 Jun; 121(4):477-80. PubMed ID: 11508507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of matrix metalloprotease-9 in middle ear cholesteatoma--correlations with growth factor expression in vivo?
    Schmidt M; Grünsfelder P; Hoppe F
    Eur Arch Otorhinolaryngol; 2001 Nov; 258(9):472-6. PubMed ID: 11769995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of the activity of MMP2 and MMP9 in middle ear cholesteatoma].
    Wang H; Xu Z; Tang A; Su J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Oct; 18(10):620-2. PubMed ID: 15620146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The expression and significance of DDR2 and MMP-13in human middle ear cholesteatoma].
    Xu LF; Sun WZ
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 30(12):938-941. PubMed ID: 29771058
    [No Abstract]   [Full Text] [Related]  

  • 13. Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer.
    Remacle AG; Noël A; Duggan C; McDermott E; O'Higgins N; Foidart JM; Duffy MJ
    Br J Cancer; 1998 Mar; 77(6):926-31. PubMed ID: 9528836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.
    Okada A; Tomasetto C; Lutz Y; Bellocq JP; Rio MC; Basset P
    J Cell Biol; 1997 Apr; 137(1):67-77. PubMed ID: 9105037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of matrix metalloproteinase (MMP-8 and -9) activities in the saliva and in gingival crevicular fluid of children with Down's syndrome.
    Halinen S; Sorsa T; Ding Y; Ingman T; Salo T; Konttinen YT; Saari H
    J Periodontol; 1996 Aug; 67(8):748-54. PubMed ID: 8866313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase -2, -8, -9, and -13 in gingival crevicular fluid of short root anomaly patients.
    Apajalahti S; Sorsa T; Ingman T
    Eur J Orthod; 2003 Aug; 25(4):365-9. PubMed ID: 12938842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a serum gelatinase associated with the occurrence of cerebral aneurysms as pro-matrix metalloproteinase-2.
    Todor DR; Lewis I; Bruno G; Chyatte D
    Stroke; 1998 Aug; 29(8):1580-3. PubMed ID: 9707196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of transforming growth factor-beta 1 matrix metalloproteinase-1 and its inhibitor in human middle ear cholesteatoma].
    Yang X; Li X; Ma M; Zhang L; Zhang Q; Wang J; Wang B
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):121-3. PubMed ID: 12768723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metalloproteinases and tissue inhibitor of metalloproteinase 1 (TIMP-1) in endometrial flushings from pre- and post-menopausal women and from women with endometrial adenocarcinoma.
    Laird SM; Dalton CF; Okon MA; Bunning RA; Marshall R; Li TC
    J Reprod Fertil; 1999 Mar; 115(2):225-32. PubMed ID: 10434927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of 72-kDa gelatinase (MMP-2), collagenase (MMP-1), and tissue metalloproteinase inhibitor (TIMP) in primary pig skin fibroblast cultures derived from radiation-induced skin fibrosis.
    Lafuma C; El Nabout RA; Crechet F; Hovnanian A; Martin M
    J Invest Dermatol; 1994 Jun; 102(6):945-50. PubMed ID: 8006459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.